M
Mandana Ashrafi
Researcher at Tehran University of Medical Sciences
Publications - 35
Citations - 2479
Mandana Ashrafi is an academic researcher from Tehran University of Medical Sciences. The author has contributed to research in topics: Placebo & Placebo-controlled study. The author has an hindex of 22, co-authored 35 publications receiving 2108 citations.
Papers
More filters
Journal ArticleDOI
Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies
TL;DR: A meta-analysis of studies comparing cytokine concentrations between patients with bipolar disorder (BD) and healthy control subjects (HCs) provides evidence for significant elevation of proinflammatory, anti-inflammatory, and regulatory cytokines in BD.
Journal ArticleDOI
Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study
Seyed Hesameddin Abbasi,Fahimeh Hosseini,Amirhossein Modabbernia,Mandana Ashrafi,Shahin Akhondzadeh +4 more
TL;DR: It is shown that celecoxib is both safe and effective as an adjunctive antidepressant (Registration number: IRCT138903124090N1) and that the antidepressant activity of cele Coxib might be linked to its capability of reducing IL-6 concentrations.
Journal ArticleDOI
Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis
Mehdi Mohamadnejad,Kamran Alimoghaddam,Mohammad Bagheri,Mandana Ashrafi,Leila Abdollahzadeh,Shahram Akhlaghpoor,Maryam Bashtar,Ardeshir Ghavamzadeh,Reza Malekzadeh +8 more
TL;DR: The uncontrolled trial showed promising results for bone marrow mesenchymal stem cell (MSC) transplantation in cirrhosis, and a randomized, placebo‐controlled trial was conducted to evaluate the efficacy of autologous MSC transplantation with promising results.
Journal ArticleDOI
Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study.
Ali Ghaleiha,Neda Entezari,Amirhossein Modabbernia,Babak Najand,Neda Askari,Mina Tabrizi,Mandana Ashrafi,Reza Hajiaghaee,Shahin Akhondzadeh +8 more
TL;DR: It was shown that memantine add-on to fluvoxamine significantly improved short-term outcomes in patients with moderate to severe OCD.
Journal ArticleDOI
Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
Mahtab Asadabadi,Mohammad Reza Mohammadi,Ahmad Ghanizadeh,Amirhossein Modabbernia,Mandana Ashrafi,Elmira Hassanzadeh,Saeedeh Forghani,Shahin Akhondzadeh +7 more
TL;DR: Combination of ris peridone and celecoxib was superior to risperidone alone in treating irritability, social withdrawal, and stereotypy of children with autism.